Literature DB >> 22144435

Case report: Peripheral polyneuropathy and mefloquine prophylaxis.

Alexander C Chester1, Paola Sandroni.   

Abstract

We describe a case of a woman who developed a peripheral polyneuropathy shortly after completing 4 weekly doses of mefloquine hydrochloride (250 mg) malaria prophylaxis. Although mefloquine-related central nervous system neuropathy is well described in the literature, peripheral polyneuropathy similar to this case has been documented only once before, to our knowledge.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22144435      PMCID: PMC3225143          DOI: 10.4269/ajtmh.2011.11-0412

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  4 in total

1.  Paresthesias and mefloquine prophylaxis.

Authors:  P E Olson; C A Kennedy; P D Morte
Journal:  Ann Intern Med       Date:  1992-12-15       Impact factor: 25.391

2.  Mefloquine toxicity presenting with polyneuropathy - a report of two cases in India.

Authors:  Sanjeev Jha; Rajesh Kumar; Raj Kumar
Journal:  Trans R Soc Trop Med Hyg       Date:  2005-10-20       Impact factor: 2.184

3.  Mefloquine-induced trigeminal sensory neuropathy.

Authors:  S Watt-Smith; K Mehta; C Scully
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2001-08

Review 4.  Mefloquine neurotoxicity: a literature review.

Authors:  Stephen Toovey
Journal:  Travel Med Infect Dis       Date:  2009-01-14       Impact factor: 6.211

  4 in total
  4 in total

1.  Idiosyncratic quinoline central nervous system toxicity: Historical insights into the chronic neurological sequelae of mefloquine.

Authors:  Remington L Nevin
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-04-05       Impact factor: 4.077

Review 2.  Psychiatric effects of malaria and anti-malarial drugs: historical and modern perspectives.

Authors:  Remington L Nevin; Ashley M Croft
Journal:  Malar J       Date:  2016-06-22       Impact factor: 2.979

3.  Prolonged Neuropsychiatric Symptoms in a Military Service Member Exposed to Mefloquine.

Authors:  Jeffrey Livezey; Thomas Oliver; Louis Cantilena
Journal:  Drug Saf Case Rep       Date:  2016-12

Review 4.  Malaria Prevention, Mefloquine Neurotoxicity, Neuropsychiatric Illness, and Risk-Benefit Analysis in the Australian Defence Force.

Authors:  Stuart McCarthy
Journal:  J Parasitol Res       Date:  2015-12-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.